Robert F. Kennedy Jr. Named New Autism Committee Chair
Health Secretary Robert F. Kennedy Jr. appointed Dr. John Gaitanis to lead the Interagency Autism Coordinating Committee.
Updated on Sept. 18, 2026 in Autism
Live Poll
Should government advisory committees be led by federal employees rather than outside experts?
Health Secretary Robert F. Kennedy Jr. has appointed pediatric neurologist Dr. John Gaitanis as the new chair of the Interagency Autism Coordinating Committee. The appointment aims to bolster federal coordination of autism-related strategic plans and initiatives.
Why it matters
The committee determined that leadership by a federal representative is essential to better align federal efforts and implement the national strategic plan. This change marks a shift in organizational strategy to prioritize executive-level oversight of autism policy.
The Interagency Autism Coordinating Committee currently consists of 21 federal representatives alongside 20 outside public members. It remains unknown how this leadership transition will affect the committee's previous advocacy for adopting the term profound autism.
The players
Robert F. Kennedy Jr.
He is the current Health Secretary who oversees federal health policy and executive appointments.
Dr. John Gaitanis
He is a pediatric neurologist and the director of the National Institutes of Health's child health institute.
Dr. Sylvia Fogel
She is a medical professional who served as the chair of the committee from January 2026 until this transition.
Interagency Autism Coordinating Committee
This federal advisory committee is responsible for coordinating autism-related efforts across multiple government agencies.
The details
Dr. John Gaitanis, who currently serves as director of the National Institutes of Health's child health institute, assumed his new role on September 18, 2026. Former chair Dr. Sylvia Fogel, who led the group since January 2026, will remain on the committee to assist with scientific data collection and meeting preparation.
Timeline
January 2026: Dr. Sylvia Fogel began her term as chair of the committee.
August 2026: Dr. John Gaitanis was appointed director of the NICHD.
September 18, 2026: Dr. John Gaitanis officially became the committee chair.
The Big Picture
This leadership appointment follows the committee's mandate to oversee the Interagency Autism Coordinating Committee's strategic plan. The move reinforces a structural emphasis on federal coordination as the primary mechanism for directing national autism policy.
The change in committee leadership may influence how federal research priorities and clinical support frameworks, such as the classification of high support needs, are implemented. Patients and families can monitor the committee's future meetings for potential changes to national healthcare guidance.
The takeaway
Effective federal oversight of complex health committees is often tied to the level of integration between appointed leadership and ongoing agency initiatives. This shift highlights a strategic preference for leadership that maintains direct ties to federal child health institutes.
Further reading
For more information on national policy, visit the Autism section.
Live Poll
Should government advisory committees be led by federal employees rather than outside experts?
